INTRODUCTION: We performed a meta-analysis on published data on the diagnostic performance of fluorine-18 dihydroxyphenylalanine ((18)F-DOPA) positron emission tomography (PET) in diagnosing and localizing focal congenital hyperinsulinism (CHI). MATERIALS AND METHODS: A comprehensive computer literature search of studies published up to 31 January 2012 regarding (18)F-DOPA PET or PET/CT in patients with CHI was performed. Pooled sensitivity and specificity, area under the ROC curve and diagnostic odds ratio (DOR) of (18)F-DOPA PET or PET/CT in diagnosing focal CHI were calculated. The localization accuracy of focal CHI was also estimated. Seven studies comprising 195 CHI patients were included. RESULTS: The pooled sensitivity and specificity of (18)F-DOPA PET or PET/CT in differentiating between focal and diffuse CHI were 89% (95% confidence interval [CI]:81-95%) and 98% (95% CI:89-100%), respectively. The DOR was 74.5 (95% CI:18-307). The area under the ROC curve was 0.95. The pooled accuracy of these functional imaging methods in localizing focal CHI was 80% (95% CI:71-88%). DISCUSSION: In CHI patients, (18)F-DOPA PET or PET/CT demonstrated high sensitivity and specificity in differentiating between focal and diffuse CHI. (18)F-DOPA PET or PET/CT are accurate methods of localizing focal CHI. Nevertheless, possible sources of false-negative results for focal CHI should be kept in mind.
INTRODUCTION: We performed a meta-analysis on published data on the diagnostic performance of fluorine-18 dihydroxyphenylalanine ((18)F-DOPA) positron emission tomography (PET) in diagnosing and localizing focal congenital hyperinsulinism (CHI). MATERIALS AND METHODS: A comprehensive computer literature search of studies published up to 31 January 2012 regarding (18)F-DOPA PET or PET/CT in patients with CHI was performed. Pooled sensitivity and specificity, area under the ROC curve and diagnostic odds ratio (DOR) of (18)F-DOPA PET or PET/CT in diagnosing focal CHI were calculated. The localization accuracy of focal CHI was also estimated. Seven studies comprising 195 CHI patients were included. RESULTS: The pooled sensitivity and specificity of (18)F-DOPA PET or PET/CT in differentiating between focal and diffuse CHI were 89% (95% confidence interval [CI]:81-95%) and 98% (95% CI:89-100%), respectively. The DOR was 74.5 (95% CI:18-307). The area under the ROC curve was 0.95. The pooled accuracy of these functional imaging methods in localizing focal CHI was 80% (95% CI:71-88%). DISCUSSION: In CHI patients, (18)F-DOPA PET or PET/CT demonstrated high sensitivity and specificity in differentiating between focal and diffuse CHI. (18)F-DOPA PET or PET/CT are accurate methods of localizing focal CHI. Nevertheless, possible sources of false-negative results for focal CHI should be kept in mind.
Authors: Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick M M Bossuyt Journal: J Clin Epidemiol Date: 2003-11 Impact factor: 6.437
Authors: I Banerjee; M Skae; S E Flanagan; L Rigby; L Patel; M Didi; J Blair; S Ehtisham; S Ellard; K E Cosgrove; M J Dunne; P E Clayton Journal: Eur J Endocrinol Date: 2011-03-04 Impact factor: 6.664
Authors: Olga T Hardy; Miguel Hernandez-Pampaloni; Janet R Saffer; Mariko Suchi; Eduardo Ruchelli; Hongming Zhuang; Arupa Ganguly; Richard Freifelder; N Scott Adzick; Abass Alavi; Charles A Stanley Journal: J Pediatr Date: 2007-02 Impact factor: 4.406
Authors: Olga T Hardy; Miguel Hernandez-Pampaloni; Janet R Saffer; Joshua S Scheuermann; Linda M Ernst; Richard Freifelder; Hongming Zhuang; Courtney MacMullen; Susan Becker; N Scott Adzick; Chaitanya Divgi; Abass Alavi; Charles A Stanley Journal: J Clin Endocrinol Metab Date: 2007-09-25 Impact factor: 5.958
Authors: Penny F Whiting; Marie E Weswood; Anne W S Rutjes; Johannes B Reitsma; Patrick N M Bossuyt; Jos Kleijnen Journal: BMC Med Res Methodol Date: 2006-03-06 Impact factor: 4.615
Authors: Milena Pizzoferro; Gabriele Masselli; Arianna Maiorana; Emanuele Casciani; Saadi Sollaku; Carlo Dionisi-Vici; Marco Spada; Claudio Altini; Maria Felicia Villani; Vittoria Rufini; Gianfranco Gualdi; Maria Carmen Garganese Journal: Am J Nucl Med Mol Imaging Date: 2022-04-15